Source: Annual Congress 2001 - Clinical biopathology of COPD / Infection /Interstitial lung disease
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. N. Avdeev, Y. M. Shulagin, O. E. Avdeeva, E. V. Stepanov, A. V. Cherniak, A. G. Chuchalin (Moscow, Russia). Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD). Eur Respir J 2001; 16: Suppl. 31, 1379

Member's Comments

No comment yet.

Related content which might interest you: Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Exhaled carbon monoxide in lung disease Source: Eur Respir J 2003; 21: 197 Year: 2003 Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002 Exhaled carbon monoxide in pulmonary sarcoidosis: clinical correlations Source: Eur Respir J 2005; 26: Suppl. 49, 79s Year: 2005 Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis Source: Eur Respir J 2002; 20: 92-99 Year: 2002 Exhaled carbon monoxide in patients with bronchiolitis obliterans after lung transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 327s Year: 2003 Exhaled carbon monoxide correlates with airway neutrophilia in patients with chronic allograft dysfunction (BOS) after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Exhaled carbon monoxide in sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 669s Year: 2004 Exhaled carbon monoxide levels during treatment of acute asthma Source: Eur Respir J 2001; 17: 1336 Year: 2001 The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Exhaled carbon monoxide in childhood asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Exhaled breath condensate pH Source: Eur Respir Monogr 2010; 49: 173-182 Year: 2010 Carbon monoxide pollution is associated with decreased lung function in asthmatic adults Source: Eur Respir J 2010; 35: 266-272 Year: 2010 Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Correlations between lung function, exhaled carbon monoxide and „lung age” in smokers versus former smokers with COPD Source: International Congress 2017 – Smoking and health hazards Year: 2017 Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004